Global Flow Cytometry Products and Services Market to Reach $6.4 Billion by 2030
The global market for Flow Cytometry Products and Services estimated at US$4.2 Billion in the year 2022, is projected to reach a revised size of US$6.4 Billion by 2030, growing at a CAGR of 5.4% over the analysis period 2022-2030. Cell-Based Flow Cytometry, one of the segments analyzed in the report, is projected to record 5.3% CAGR and reach US$3.8 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Bead-Based Flow Cytometry segment is readjusted to a revised 5.6% CAGR for the next 8-year period.The U.S. Market is Estimated at $1.1 Billion, While China is Forecast to Grow at 8.9% CAGR
The Flow Cytometry Products and Services market in the U.S. is estimated at US$1.1 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$1.4 Billion by the year 2030 trailing a CAGR of 8.9% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 1.9% and 5.8% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 3% CAGR.Select Competitors (Total 42 Featured) -
- Agilent Technologies, Inc.
- Apogee Flow Systems Ltd.
- Beckman Coulter, Inc.
- Becton, Dickinson and Company
- bioMerieux SA
- Bio-Rad Laboratories, Inc.
- Cytonome/ST, LLC
- Enzo Life Sciences, Inc.
- Luminex Corporation
- Merck KGaA
- Miltenyi Biotec GmbH
- Sony Biotechnology, Inc.
- Stratedigm, Inc.
- Sysmex Partec GmbH
- Thermo Fisher Scientific, Inc.
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERSIII. MARKET ANALYSISCANADAITALYSPAINRUSSIAREST OF EUROPESOUTH KOREAREST OF ASIA-PACIFICARGENTINABRAZILMEXICOREST OF LATIN AMERICAIRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EASTIV. COMPETITION
1. MARKET OVERVIEW
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
UNITED KINGDOM
ASIA-PACIFIC
AUSTRALIA
INDIA
LATIN AMERICA
MIDDLE EAST
AFRICA
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Agilent Technologies, Inc.
- Apogee Flow Systems Ltd.
- Beckman Coulter, Inc.
- Becton, Dickinson and Company
- bioMerieux SA
- Bio-Rad Laboratories, Inc.
- Cytonome/ST, LLC
- Enzo Life Sciences, Inc.
- Luminex Corporation
- Merck KGaA
- Miltenyi Biotec GmbH
- Sony Biotechnology, Inc.
- Stratedigm, Inc.
- Sysmex Partec GmbH
- Thermo Fisher Scientific, Inc.
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 174 |
Published | April 2024 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 4.2 Billion |
Forecasted Market Value ( USD | $ 6.4 Billion |
Compound Annual Growth Rate | 5.4% |
Regions Covered | Global |